Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other financing activities (2019)

Black Diamond Therapeutics' Other financing activities history spans 1 years, with the latest figure at $1.3 million for Q4 2019.

  • For Q4 2019, Other financing activities changed N/A year-over-year to $1.3 million; the TTM value through Dec 2020 reached $1.7 million, changed N/A, while the annual FY2019 figure was $1.7 million, N/A changed from the prior year.
  • Other financing activities reached $1.3 million in Q4 2019 per BDTX's latest filing, up from $338000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.3 million in Q4 2019 to a low of $338000.0 in Q3 2019.